Best supportive care for patients with primary progressive multiple sclerosis (PPMS) in Germany prior to ocrelizumab treatment: Final results from the RETRO PPMS study

Authors: Herbert Schreiber, Iris-Katharina Penner, Tanja Maier, Stefanie Hieke-Schulz, Jost Leemhuis, Tjalf Ziemssen

Source: Journal of Central Nervous System Disease, Vol 16 (2024)

Subject Terms: Neurology. Diseases of the nervous system, RC346-429

File Description: electronic resource

Relation: https://doaj.org/toc/1179-5735

Access URL: https://doaj.org/article/a186cc90843e4577891e37c3c036ce53

Safety, Adherence and Persistence in a Real-World Cohort of German MS Patients Newly Treated With Ocrelizumab: First Insights From the CONFIDENCE Study

Authors: Martin S. Weber, Mathias Buttmann, Sven G. Meuth, Petra Dirks, Erwan Muros-Le Rouzic, Julius C. Eggebrecht, Stefanie Hieke-Schulz, Jost Leemhuis, Tjalf Ziemssen

Source: Frontiers in Neurology, Vol 13 (2022)

Subject Terms: neurodegenerative diseases, multiple sclerosis, non-interventional study (NIS), real-world cohort, safety, drug (or treatment) persistence, Neurology. Diseases of the nervous system, RC346-429

File Description: electronic resource

Relation: https://www.frontiersin.org/articles/10.3389/fneur.2022.863105/full; https://doaj.org/toc/1664-2295

Access URL: https://doaj.org/article/5c361ada58c94ccf8af5b50ba90fce7e

Design of a non-interventional post-marketing study to assess the long-term safety and effectiveness of ocrelizumab in German real world multiple sclerosis cohorts – the CONFIDENCE study protocol

Authors: Petra Dirks, Vera Zingler, Jost Leemhuis, Heike Berthold, Stefanie Hieke-Schulz, David Wormser, Tjalf Ziemssen

Source: BMC Neurology, Vol 20, Iss 1, Pp 1-9 (2020)

Subject Terms: Ocrelizumab, Relapsing multiple sclerosis, Primary progressive multiple sclerosis, Real world data, Non-interventional study, Long-term safety and effectiveness, Neurology. Diseases of the nervous system, RC346-429

File Description: electronic resource

Relation: http://link.springer.com/article/10.1186/s12883-020-01667-7; https://doaj.org/toc/1471-2377

Access URL: https://doaj.org/article/d8e9e8de57af437a984b0d10fb418cba

Reasons to switch: a noninterventional study evaluating immunotherapy switches in a large German multicentre cohort of patients with relapsing-remitting multiple sclerosis

Authors: Mathias Mäurer, Klaus Tiel-Wilck, Eckard Oehm, Nils Richter, Michael Springer, Patrick Oschmann, Arndt Manzel, Stefanie Hieke-Schulz, Vera Zingler, Julia A. Kandenwein, Tjalf Ziemssen, Ralf A. Linker

Source: Therapeutic Advances in Neurological Disorders, Vol 12 (2019)

Subject Terms: Neurology. Diseases of the nervous system, RC346-429

File Description: electronic resource

Relation: https://doaj.org/toc/1756-2864

Access URL: https://doaj.org/article/0fd09a02da39460790244fd7336013fa